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Patients receiving total intravenous anesthesia (TIVA) with propofol have been shown to
experience less postoperative pain. We evaluated the post-operative analgesic effects of
propofol compared with sevoflurane maintenance of anesthesia in liver surgery. This study
was registered at ClinicalTrials.gov (NCT02179437).
Methods
In this retrospective study, records of patients who underwent liver surgery between 2010
and 2013 were reviewed. Ninety-five patients anesthetized with propofol TIVA were
matched with 95 patients anesthetized with sevoflurane. Numeric pain rating scale (NRS)
pain scores, postoperative morphine consumption, side effects and patients’ satisfaction
with pain relief were evaluated.
Results
The TIVA group reported lower NRS pain scores during coughing on postoperative days 1
and 2 but not 3 (p = 0.0127, p = 0.0472, p = 0.4556 respectively). They also consumed sig-
nificantly less daily (p = 0.001 on day 1, p = 0.0231 on day 2, p = 0.0004 on day 3), accumu-
lative (p = 0.001 on day 1, p<0.0001 on day 2 and p = 0.0064 on day 3) and total morphine
(p = 0.03) when compared with the sevoflurane group. There were no differences in total
duration of intravenous patient controlled analgesia (PCA) morphine use and patient satis-
faction. No difference was found in reported side effects.
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Conclusion
Patients anesthetized with propofol TIVA reported less pain during coughing and consumed
less daily, accumulative and total morphine after liver surgery.
Introduction
Postoperative pain can be severe after liver surgery due to the upper abdominal incision and pain
management can be difficult for this group of patients [1]. Epidural analgesia is relatively contra-
indicated due to impaired postoperative coagulation profiles and, consequently, large doses of
strong opioids may be required in order to achieve adequate pain control. As shown in an audit
of postoperative intravenous patient-controlled analgesia (PCA), patients who underwent hepa-
tobiliary and pancreatic surgery were found to report moderate to severe pain scores and high
morphine consumption [2]. In addition, liver resection impair opioid metabolism, as reflected by
higher plasma morphine concentrations in patients after hepatectomy compared with those after
colon resection, leading to a higher incidence of side effects such as sedation [3]. Therefore, opi-
oid-sparing multimodal pain treatment is important for fast-track recovery after liver resection
[4]. Identification of novel analgesic techniques is of utmost importance to achieve this goal.
Propofol (2,6-diisopropylphenol) is an intravenous anesthetic. Its pharmacokinetic profile
makes it very suitable for total intravenous anesthesia (TIVA) and this is a widely used tech-
nique in many centers [5, 6]. Its use results in a rapid onset and offset with fewer side effects
including postoperative nausea and vomiting, making it particularly favorable in the ambula-
tory setting [7]. Studies have been conducted to explore possible anti-nociceptive mechanisms
of propofol and its potential role as an analgesic clinically. In animal studies, propofol has been
shown to directly depress the dorsal horn neurons in the spinal cord [8], inhibit the phosphory-
lation of N-methyl-D-aspartate receptor NR1 subunit [9], and inhibit the cannabinoid CB1
and CB2 receptors [10]. In human volunteers, hypnotic doses of propofol at 3.5 mcg/ml
decreased pain-related regional blood flow to the thalamus and anterior cingulate cortex [11].
Propofol significantly decreased pain scores by 40% and areas of hyperalgesia and allodynia in
human volunteers [12]. Work on propofol’s preferential binding to the HCN1 pacemaker
channels further reinforce its anti-hyperalgesic effects [13, 14]. Propofol has been shown to be
anti-inflammatory, both in vitro [15] and in human studies [16], which may play an essential
role in post-operative analgesia.
The aim of this retrospective study is to evaluate the analgesic effects (pain scores at rest and
during coughing and daily, accumulative and total opioid consumption) of intraoperative use
of propofol TIVA in liver surgery. The data from patients receiving TIVA with propofol were
matched with those receiving the inhalational anesthetic sevoflurane. Tolerability (side effects)
and patients’ satisfaction with pain relief were also assessed.
Methods
The study was approved by the Institutional Review Board of Queen Mary Hospital and the
University of Hong Kong and registered at ClinicalTrials.gov (NCT02179437). As this was a
retrospective study, there was no requirement to obtain written informed consent from
patients. The data was delinked from patient identifiers and anonymized prior to analysis so
that none of the researchers were aware of patient identification. Records of patients after liver
surgery and under the care of the acute pain service (APS) between 1 January 2010 and 31
December 2013 in our tertiary university hospital were reviewed and analyzed. Data collected
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included demographic data (age, body weight, gender and American Society of Anesthesiolo-
gists (ASA) physical status); types of liver surgery performed (left or right hepatectomy, seg-
mentectomy and wedge resection were considered as hepatectomy and radio-frequency
ablation or microwave ablation were considered as RFA); types of general anesthesia tech-
niques (total intravenous anaesthesia with propofol, inhalational anaesthesia with sevoflurane);
with or without intraoperative use of ketamine; pain intensity as verbal numerical rating scale
(NRS, 0 = no pain, 10 = the worst imaginable pain) at rest and during coughing from postoper-
ative days 1 to 3; daily, accumulative and total postoperative morphine consumption and dura-
tion of PCA use; incidence of adverse events and patients’ satisfaction with pain relief.
Exclusion criteria were missing essential data, difficulty in assessment of postoperative pain
(e.g. postoperative mechanical ventilation, language barriers), early termination of PCA due to
deterioration of patients’ condition, patients requiring a second operation and patients partici-
pating in other research projects.
None of the patients in this study received premedication. Patients in the TIVA group had
anesthesia induced and maintained with propofol. For patients in the SEVO group, general
anesthesia was induced with propofol 1–2 mg/kg and then maintained with sevoflurane in air
and oxygen, titrated according to heart rate and blood pressure by the attending anesthesiolo-
gist. Cis-atracurium 0.15 mg/kg or rocuronium 0.6 mg/kg was administered to facilitate tra-
cheal intubation. All patients were given a bolus of remifentanil 1mcg/kg before intubation and
then an infusion titrated to hemodynamic response and maintained up to 0.2 mcg/kg/min dur-
ing surgery. Morphine 0.1 mg/kg was given intravenously before incision. Additional mor-
phine 0.1 mg/kg was given in divided doses at the discretion of the attending anesthesiologist if
surgery continued for more than 2 hours. Ketamine 0.5–1 mg/kg was given at the discretion of
the attending anesthesiologist. Wound infiltration with 0.5% levobupivacaine (up to 2 mg/kg)
was performed by the surgeon during wound closure. After completion of surgical procedures,
reversal of neuromuscular blockade was achieved with atropine 0.02 mg/kg and neostigmine
0.05 mg/kg, followed by tracheal extubation.
In the post anesthesia care unit (PACU), vital signs including blood pressure, oxygen satura-
tion (SpO2) and heart rate were monitored. A 2 mg bolus of morphine was given intravenously
every five minutes until the patient’s verbal numerical rating scale (NRS) was three or below. A
PCA device (Graseby 3300 Syringe Pump, Smiths Medical, London), configured to give mor-
phine at 1 mg per bolus with a five-minute lockout duration and a maximum dose limit of 0.1
to 0.15 mg/kg/hour, with the continuous basal infusion mechanism disabled, was connected
for use. Subcutaneous or intramuscular morphine injection (0.05 mg/kg) was prescribed as res-
cue pain medication. Anti-emetics were not routinely administered for prophylaxis of postop-
erative nausea and vomiting (PONV), although intravenous ondansetron 4 mg 6 hourly was
prescribed routinely, to be given if required.
Oral fluid intake started on postoperative day 1 if no surgical complications were apparent.
Regular oral analgesics including tramadol, COX-2 inhibitors and/or paracetamol, were then
started. The APS team were informed if pain control was inadequate and hourly limit and
bolus dose parameters could then be adjusted after assessment. All the patients were visited
daily by anesthesiologists from the APS team and postoperative pain scores at rest and during
coughing, daily PCA morphine consumption and side effects were recorded until discharge
from the APS. Criteria for cessation of PCA use included NRS of less than 3 during coughing,
daily morphine consumption less than 0.1 mg/kg, or patients’ request. Rescue pain medication
and adjuvant oral pain medication continued after cessation of PCA use. Patients were asked
by the APS team to grade their satisfaction regarding the pain service as ‘good’, ‘fair’ or ‘unsat-
isfactory’ at the time of PCA discontinuation. They were also asked for reason(s) if they
reported an ‘unsatisfactory’ pain service.
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A retrospective power calculation was performed for this study. Using NRS during coughing
on day 1 as the primary outcome, the mean (SD) of the TIVA group was found to be 4.301
(1.986), while the mean of the SEVO group was 5.08, at 80% power and an alpha of 0.05, 52
subjects would be required in each group.
Each patient who received TIVA was matched 1:1 to patients who had received sevoflurane
according to age, gender, ASA physical status, types of liver surgery performed (hepatectomy
vs radio-frequency ablation) and with or without intraoperative use of ketamine [17]. This one
to one patient matching is a more comprehensive method than using the propensity score [18,
19]. Patient demographics are presented as means (SD) for parametric data, and percentage
where appropriate. Differences in pain scores were tested for using unpaired t-test with Welch’s
correction, while Mann-Whitney test was used to look at differences in morphine use. Differ-
ences in post-operative side effects and overall satisfaction was tested for using Fisher’s Exact
test. Statistical Package for the Social Sciences (SPSS Statistics version 20, IBM Corp., USA) sta-
tistical software was used for data analysis.
Results
One thousand two hundred and eighty two records of patients who underwent liver surgery
under the management of the APS team were screened. It was found that 95 patients had
received TIVA with propofol as maintenance of general anaesthesia during the specified
period, while 720 patients received sevoflurane. Patient demographics are shown in Table 1.
No statistically significant differences were seen between the two groups in either the duration
of surgery or the use of intraoperative opioid.
Pain scores as NRS at rest and during coughing for the first three postoperative days are pre-
sented in Table 2. There were no significant differences in NRS pain score at rest between the
two groups. The TIVA group reported a lower NRS pain score on coughing with a mean of
4.301 and 4.000 on postoperative days 1 and 2 respectively (p<0.05), but no differences
between the groups was seen on day 3.
Daily morphine consumption is shown in Table 3. There was a reduced daily mean mor-
phine consumption in the TIVA group on postoperative days 1 to 3 (8 mg vs 12 mg, p = 0.001
on day 1, 9.0 mg vs 13.0 mg, p = 0.0231 on day 2 and 16.0 mg vs 28.0 mg on day 3, p = 0.0004).
Total PCA morphine consumption was also less in the TIVA group when compared with the
SEVO group (p = 0.03). However, there was no difference in duration of PCA use (59 hours in
both groups, Table 4).
No difference was seen between the number of patients suffering from nausea, dizziness and
pruritus in either group, and only the incidence of pruritus was lower in the TIVA group
(p = 0.029). Since side effects were a rare occurrence in both treatment groups, and though
Table 1. Patient demographics, duration of surgery and total intraoperative opioid use. Values in means ± SD (range) or %.
SEVO(n = 95) TIVA(n = 95)
Age (years) 60.24 ± 10.40(31–83) 60.72 ± 10.33(32–89)
Body weight (kg) 63.71 ± 12.15(45–100) 61.66 ± 11.64(34–102)
Sex, M: F 73:23 73:23
ASA, I: II: III 5:63:27 3:61:31
Surgery type, RFA: Hepatectomy 23:77 23:77
Ketamine: no ketamine use 82:18 89:11
Duration of surgery (mins) 368.7 ± 206.3(74.0–1235) 357.6 ± 194.6(119.0–1079)
Total intraoperative opioid use 267.5 ± 190.4(0.0–925.0) 326.4 ± 459.9(0.0–3959)
doi:10.1371/journal.pone.0149753.t001
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statistical analyses and comparisons were performed, the low rate of events renders the power
to detect differences in side effects to be very low (Table 5). Seventy five point eight percent of
patients in the TIVA group and 77.9% of patients in the SEVO group graded overall satisfac-
tion as ‘fair’, and no differences in overall satisfaction was seen (Table 6).
Discussion
Our study showed that patients receiving propofol for maintenance of general anaesthesia in
liver surgery reported significantly less pain as reflected by lower mean NRS pain scores during
coughing and less daily, accumulative and total postoperative morphine consumption. With a
large upper abdominal wound, high doses of strong opioids may be required for pain control
but its side effects may become apparent as morphine metabolism is impaired after liver resec-
tion, especially for those with liver cirrhosis and impaired liver function [3]. There are also
restrictions in analgesic selection. Paracetamol is not routinely prescribed for fear of drug
induced hepatotoxicity in patients who have undergone hepatectomy and, if prescribed, the
dose should be limited to 2–3 g/day [1, 20]. In view of possible thrombocytopenia secondary to
hypersplenism, deranged clotting profile, potential major blood loss, and renal impairment
from the hepatorenal syndrome, non-steroid anti-inflammatory drugs (NSAID) are relatively
contraindicated [1, 20]. Although epidural analgesia using morphine and ketamine [21], bupi-
vacaine and fentanyl [22], or a single bolus of preoperative intrathecal morphine [23] have
been shown to provide reasonable pain relief after liver resection surgery, those patient groups
had predominantly undergone liver resection for colorectal metastasis [22] or were healthy
liver donors for right hepatectomy [23]. The complication of epidural hematoma is devastating
and patients with cirrhosis, thromobocytopenia and post liver resection coagulopathy are at
particular risk, such that most anesthesiologists will avoid epidural analgesia in this setting. It
is important to achieve good acute pain control to prevent progression to chronic pain and
facilitate early mobilization. It has been shown that higher postoperative morphine consump-
tion at 24 hours is predictive of the development and severity of chronic pain [24]. Therefore,
post-operative pain control in this group of patients can be a major challenge [1]. Propofol was
Table 2. Postoperative pain scores. Values in means (SD).
SEVO(n = 95) TIVA(n = 95) p value
NRS Pain scores at rest
Day 1 2.159 (1.825) 1.771 (1.655) 0.1468
Day 2 1.307 (1.307) 1.376 (1.456) 0.7412
Day 3 1.100 (1.199) 1.180 (1.466) 0.7659
NRS Pain scores during coughing
Day 1 5.080 (2.052) 4.301 (1.986) 0.0127
Day 2 4.563 (1.796) 4.000 (1.896) 0.0472
Day 3 4.380 (1.872) 4.120 (1.586) 0.4556
NRS = Numerical Rating Scale
doi:10.1371/journal.pone.0149753.t002
Table 3. Daily Morphine consumption (mg) from postoperative day 1 to 3. Values in median, [range]
(mean).
SEVO TIVA P value
Day 1 12.0[1–61.0](15.76) 8.0[0–55.0](10.21) 0.001
Day 2 13.0[1.00–74.0](16.50) 9.0[0–81.0](13.55) 0.0231
Day 3 28.0[7.0–85.0](31.51) 16.0[1–61.0](18.74) 0.0004
doi:10.1371/journal.pone.0149753.t003
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primarily developed as an anesthetic and sedative drug and the potential analgesic effect is an
interesting and serendipitous discovery [25]. With regard to acute pain, a study by Cheng and
colleagues showed that propofol was associated with less postoperative pain and less self-
administered morphine when compared with isoflurane in the first day after open uterine sur-
gery [25]. Two further studies found that patients who underwent laparoscopic gynecological
surgery under propofol anesthesia reported less pain over the immediate postoperative period
compared with those receiving sevoflurane. In the study where Li and colleagues studied 90
patients, the pain scores at rest at 0.5 hour and 1 hour postoperatively were significantly lower
in the propofol group compared with the sevoflurane group [26]. Tan et al found that the pain
scores were significantly higher in the sevoflurane group when compared with the propofol
group over the immediate postoperative 4 hour period [27]. In a study of pediatric patients
undergoing hernia repair, propofol use was found to be associated with a lower proportion of
patients exhibiting postoperative pain when compared with sevoflurane [28]. On the contrary,
a study comparing sevoflurane and propofol found no difference in cumulative opioid con-
sumption and pain scores at rest or after cough at postoperative 2, 4, 8 and 24 hours after
abdominal hysterectomy or myomectomy [29]. Anesthetic techniques as propofol TIVA are
potentially useful in decreasing postoperative pain and opioid consumption, especially in fast
track surgery [4] and should be considered an option for reducing postoperative pain.
In contrast to previously mentioned studies which measured pain scores at rest [26], our
study demonstrated a reduction in pain scores during coughing which is important in chest
physiotherapy and mobilization, especially with large upper abdominal wounds. In addition,
compared with other studies which measured pain scores from 0.5 to 24 hours postoperatively
[25–27], our study showed that the decrease in pain scores extended to postoperative day 2,
with less daily morphine consumption up to day 3. This makes it very unlikely that the reduc-
tion in pain scores and morphine consumption within the first 24 hours is due to a sedative
effect from residual anesthetics because propofol has a very fast recovery profile. Although
there was no decrease in pain scores at rest and total duration of PCA use, the decrease in total
morphine consumption by 28% in our study is both statistically and clinically significant.
As well as improving patient comfort, adequate relief of pain on movement and during
coughing is important in reducing risks of cardiopulmonary and thromboembolic complica-
tions after surgery [30]. In addition, immobilization after surgery is a known risk factor for the
development of chronic hyperalgesia [31], affecting around 1% of surgical patients. Effective
relief of pain on movement post-surgery is, therefore, important to improve long-term out-
come [30, 31].
Table 4. Total post-operative morphine consumption (mg) and duration of PCA use. Values in median
[IQR] (range).
SEVO(n = 95) TIVA(n = 95) P value
Total PCA morphine consumption (mg) 30 [18–58.25](1–154) 21.5 [9.75–40.25](1–453) 0.03
PCA duration (hours) 59 [43.75–70.5](20–114) 59 [43–68](14–136) 0.9857
doi:10.1371/journal.pone.0149753.t004
Table 5. Postoperative side effects. Values in n (%).
SEVO(n = 95) TIVA (n = 95) P value
Nausea 15 (15.8%) 11 (11.6%) 0.527
Vomiting 6 (6.3%) 6 (6.3%) 1.00
Dizziness 5 (5.3%) 1 (1.1%) 0.211
Pruritus 6 (6.3%) 0 (0%) 0.029
Postoperativedelirium 0 0 1.00
doi:10.1371/journal.pone.0149753.t005
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Propofol’s exact mechanism of action remains unknown, though both cell culture and ani-
mal studies suggest that it is through interaction with GABAA receptors that propofol exerts its
anesthetic as well as its analgesic effects [14, 25, 32, 33]. Animal studies employing the delta
opioid antagonist naltrindole suggests that as well as working through the GABAA receptors,
propofol antinociception is also mediated by a spinal delta opioid receptor [32]. Another
potential route through which propofol exerts its analgesic effect [34] is through its anti-
inflammatory [35] and antioxidant action [36].
With regard to side effect profiles, our results showed no difference in the incidence of nau-
sea, vomiting, dizziness, or post-operative delirium between the SEVO and the TIVA groups,
although pruritus was significantly lower in the TIVA group. It is to be noted here that this
study was not powered to detect side effects with a low incidence and, essentially, raw data
does show that 15.8% of the SEVO group had nausea, versus 11.6% in the TIVA group, while
5.3% in the SEVO group reported dizziness, versus 1.1% in the TIVA group.
There are several limitations to this study. Firstly, this was retrospective with data retrieved
from a registry. We did not utilize a standardized target for maintenance of depth of general
anesthesia such as processed EEG. Another limitation is the interplay between drugs and
hepatic function. There is uncertainty about the remaining liver function after hepatectomy
compared with radiofrequency ablation, although studies have shown that patients who
received radiofrequency ablation exhibited less derangement in albumin and bilirubin levels on
postoperative day 7 [37]. In addition, it is unclear how hepatic function affects the metabolism
of sevoflurane, propofol and morphine. With regard to propofol, studies have shown no
requirement to change the infusion dose in patients with moderate cirrhosis [38, 39]. Sevoflur-
ane, being an inhalational anesthetic with low blood:gas solubility undergoes only 2–5% metab-
olism by the liver [40]. Although we did not measure postoperative sedation, the possibility
that patients may become more sedated and hence consume less morphine because of residual
anesthetic was unlikely as our result showed the decrease in NRS pain scores during coughing
was still apparent at postoperative day 2 and daily morphine consumption was also lower, out-
lasting the therapeutic duration of both sevoflurane and propofol.
In conclusion, patients who underwent liver surgery using propofol for induction and main-
tenance of anesthesia had less pain during coughing on postoperative days 1 and 2 and reduced
daily, accumulative and total postoperative morphine consumption when compared to the use
of sevoflurane. No difference was found in pain at rest on post-operative day 1 to 3, total dura-
tion of PCA use and patients’ satisfaction with pain relief. The incidence of post-operative nau-
sea, dizziness and pruritus was lower in the TIVA group.
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